T 1872/16 (IL-13 antibodies for the treatment of severe asthma/GLAXO) of 23.07.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T187216.20190723
- Date of decision
- 23 July 2019
- Case number
- T 1872/16
- Petition for review of
- -
- Application number
- 11181891.0
- IPC class
- C07K 16/24A61P 37/08A61P 37/02
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Chimeric and humanised monoclonal antibodies against interleukin-13
- Applicant name
- Glaxo Group Limited
- Opponent name
- Leeming, John Gerard
UCB Biopharma SPRL - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56 (2007)European Patent Convention Art 83 (2007)
- Keywords
- Sufficiency of disclosure of further medical use
Sufficiency of disclosure - main request (no)
Sufficiency of disclosure - auxiliary requests 1, 2, 4, 5 (no)
Inventive step - auxiliary request 3 (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.